- Oct 26/21
Exacis Biotherapeutics announces strategic partnership with CCRM for specialty manufacturing of services and investment for development of iPSC-derived mRNA-engineered NK cells - Oct 26/21
Final ‘foundation stones’ set for future of Australian regenerative medicine - Oct 26/21
U of T researchers’ lab-grown muscles used to study Duchenne muscular dystrophy, develop treatments - Oct 25/21
Exacis Biotherapeutics partners with CCRM - Oct 25/21
We need to ground truth assumptions about gene therapy - Oct 24/21
U of T researchers make stem cells repair muscle tissue - Oct 22/21
Nudging cells to repair damaged retinas - Oct 21/21
New mechanism of muscle repair revealed - Oct 21/21
Researchers create stem cell models of Alzheimer’s from post-mortem tissue - Oct 21/21
Ten years on, gene therapy still beating most cases of ‘bubble boy’ immune disease - Oct 20/21
Four success stories in gene therapy - Oct 19/21
The definition of gene therapy has changed - Oct 19/21
25 years of VST therapies: the journey behind the technology and innovation - Oct 19/21
AVROBIO Inc. (AVRO) reports new interim safety data across investigational gene therapies for Fabry and Gaucher disease type 1 - Oct 18/21
Researchers report long-lasting effects of gene therapy in children with deadly immune disorder - Oct 18/21
A new method — inspired by kids’ pop-up books — for making 3D artificial tissue - Oct 18/21
A regenerative reset for ageing - Oct 17/21
Researchers shed new light on the inner workings of stem cells - Oct 15/21
Labs are getting smaller, smarter and forcing landlords to pivot quickly - Oct 14/21
Aided by stem cells, a lizard regenerates a perfect tail for first time in more than 250 million years - Oct 14/21
New method for testing muscle repair in a dish to impact development of stem cell-based therapies - Oct 13/21
Challenges in analytical development and testing for gene therapies - Oct 13/21
Landmark treatment: Cell therapy advances options for corneal endothelial disease - Oct 13/21
Research to investigate stem cell therapy as potential glaucoma treatment - Oct 11/21
Drug developed at Duke is approved by FDA as only therapy for congenital athymia - Oct 11/21
Cloaking technology: helping therapeutic cells evade your immune system - Oct 11/21
Gene therapy to restore vision after stroke - Oct 8/21
Researchers identify a stem cell population with enhanced fracture healing and differentiation abilities - Oct 8/21
New approach to guided nerve repair by using gingiva-derived mesenchymal stem cells - Oct 7/21
Australian researchers hope to switch on sight with new gene therapy - Oct 7/21
Novel mechanism sheds light on embryonic stem cell pluripotency - Oct 7/21
Killer cells: delivering a knockout blow to cancers - Oct 7/21
Molecular mechanisms of stem cell rolling revealed - Oct 6/21
AVROBIO to present new clinical and preclinical data across multiple programs at the ESGCT 28th Annual Congress - Oct 5/21
CAR-T cells require an abundance of antigens to efficiently kill solid tumours - Oct 5/21
CNS activity in acute leukemia no barrier to CAR-T remissions - Oct 4/21
Cell therapy manufacturing shifts to automatic - Oct 4/21
Is stathmin-2 the next piece of the ALS jigsaw puzzle - Oct 4/21
Making the transition from an academic to a biobusiness entrepreneur - Oct 4/21
CRISPR gene therapies: Assessing the success of gene edits using ddPCR - Oct 4/21
Japan’s Fujifilm promotes industrial application of iPS cell-derived regenerative medicine - Oct 3/21
Scientists reverse pancreatic cancer progression in “time machine” made of human cells - Oct 2/21
Gene therapy can restore vision after stroke - Oct 2/21
FDA nod for Tecartus, first CAR-T for relapsed or refractory B-cell ALL in adults - Oct 1/21
Study reveals how the blood and immune systems develop in prenatal bone marrow - Sept 30/21
For gene therapies, FDA drafts trial guidance, finalizes “sameness” for orphan exclusivity - Sept 30/21
Scientists reverse pancreatic cancer progression in “time machine” made of human cells - Sept 29/21
Stem-cell startups seek to crack the mass-production problem - Sept 29/21
The stem cell revolution isn’t what you think it is - Sept 29/21
Gene editing breakthroughs accelerate heart, stroke research - Sept 29/21
Pfizer modifies MD gene therapy trial after three serious adverse events
